Award Year / Program / Phase:
2010 / STTR / Phase I
Agency:
HHS
Research Institution:
Fred Hutchinson Cancer Research Center
DESCRIPTION (provided by applicant): Over 90% of cancer patients that enroll in Phase I or II clinical trials experience no benefit from the experimental therapies, yet are exposed to drug toxicity and other challenges related to treatment. For over 50 years, physicians have used patient-specific…
More